Small-cell lung cancer patients are just 'a little bit' tired: response shift and self-presentation in the measurement of fatigue

被引:35
|
作者
Westerman, Marjan J.
The, Anne-Mei
Sprangers, Mirjam A. G.
Groen, Harry J. M.
van der Wal, Gerrit
Hak, Tony
机构
[1] VU Univ, Ctr Med, Dept Publ & Occupat Hlth, EMGO Inst, NL-1081 BT Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Psychol Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Groningen Hosp, Dept Pulm Dis, Groningen, Netherlands
[4] Erasmus Univ, RSM, Rotterdam, Netherlands
关键词
small-cell lung cancer; quality of life; response shift; self-presentation; fatigue;
D O I
10.1007/s11136-007-9178-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Response shift has gained increasing attention in the measurement of health-related quality of life (QoL) as it may explain counter-intuitive findings as a result of adaptation to deteriorating health. Objective To search for response shift type explanations to account for counter-intuitive findings in QoL measurement. Methods Qualitative investigation of the response behaviour of small-cell lung cancer (SCLC) patients (n = 23) in the measurement of fatigue with The European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) question 'were you tired'. Interviews were conducted at four points during 1st line chemotherapy: at the start of chemotherapy, 4 weeks later, at the end of chemotherapy, and 6 weeks later. Patients were asked to 'think aloud' when filling in the questionnaire. Results Fifteen patients showed discrepancies between their answer to the EORTC question 'were you tired' and their level of fatigue spontaneously reported during the interview. These patients chose the response options 'not at all' or 'a little' and explained their answers in various ways. In patients with and without discrepancies, we found indications of recalibration response shift (e.g. using a different comparison standard over time) and of change in perspective (e.g. change towards a more optimistic perspective). Patients in the discrepancy group reported spontaneously how they dealt with diagnosis and treatment, i.e. by adopting protective and assertive behaviour and by fighting the stigma. They distanced themselves from the image of the stereotypical cancer patient and presented themselves as not suffering and accepting fatigue as consequence of treatment. Conclusion In addition to response shift, this study suggests that 'self-presentation' might be an important mechanism affecting QoL measurement, particularly during phases when a new equilibrium needs to be found.
引用
收藏
页码:853 / 861
页数:9
相关论文
共 50 条
  • [31] Role of surgery in patients with early stage small-cell lung cancer
    Peng, Aimei
    Li, Guoshu
    Xiong, Mengting
    Xie, Shuanshuan
    Wang, Changhui
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7089 - 7101
  • [32] Survival of Patients with Small-Cell Lung Cancer Undergoing Surgical Resection
    Kikuchi, S.
    Okamura, J.
    Araki, K.
    Yanagihara, T.
    Nakaoka, K.
    Kitazawa, Y.
    Kobayashi, N.
    Goto, Y.
    Minami, Y.
    Onizuka, M.
    Ichimura, H.
    Sato, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S578 - S579
  • [33] SMALL-CELL LUNG-CANCER IN ELDERLY PATIENTS - THE CASE FOR CHEMOTHERAPY
    KELLY, P
    OBRIEN, AAJ
    DALY, P
    CLANCY, L
    AGE AND AGEING, 1991, 20 (01) : 19 - 22
  • [34] PHARMACOKINETICS AND PHARMACODYNAMICS OF DOXORUBICIN IN PATIENTS WITH SMALL-CELL LUNG-CANCER
    PISCITELLI, SC
    RODVOLD, KA
    RUSHING, DA
    TEWKSBURY, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (05) : 555 - 561
  • [35] Stereotactic radiosurgery for patients with small-cell lung cancer brain metastases
    Rieken, Stefan
    LANCET ONCOLOGY, 2022, 23 (07): : 832 - 833
  • [36] RETURN TO WORK AMONG PATIENTS WITH SMALL-CELL LUNG-CANCER
    BERGMAN, B
    SORENSON, S
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1987, 70 (01): : 49 - 53
  • [37] Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
    Blackhall, Fiona
    Frese, Kristopher K.
    Simpson, Kathryn
    Kilgour, Elaine
    Brady, Ged
    Dive, Caroline
    LANCET ONCOLOGY, 2018, 19 (09): : E470 - E481
  • [38] The clinical application of atorvastatin in patients with small-cell lung cancer with dyslipidemia
    Kong, Fanming
    Wang, Na
    Gao, Fangfang
    Liang, Yangyueying
    Li, Longhui
    Yu, Minghui
    Zhao, Lu
    Zhang, Dou
    Jia, Yingjie
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (15) : 13697 - 13704
  • [39] Pharmacokinetics of antitumor drug Platin in patients with small-cell lung cancer
    Kulik, GI
    Solyanik, GI
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R461 - R461
  • [40] PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG-CANCER
    BUNN, PA
    KELLY, K
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (03) : 161 - 162